Recruiting

Aromatherapy for Mental Health Promotion in IVF Patients

The experience of infertility can cause significant emotional instability, especially for patients awaiting In Vitro Fertilization (IVF) treatment, generating anxiety, stress, and depressive symptoms. This study is a randomized clinical trial assessing the effectiveness of aromatherapy in improving mental health and quality of life in women undergoing infertility treatment. 120 participants will be randomized into three groups (Intervention, Placebo, and Control). The intervention involves the inhalation of true…

ClinicalTrials.gov IDNCT07480668
PhaseNA
Enrollment120
SponsorFederal University of Minas Gerais
Age18 Years
SexFEMALE
I'm interested View official listing

Conditions studied

Anxiety, Stress, Depression Disorder, Quality of Life, Aromatherapy, IVF, Complementary Therapies, Spirituality, Infertility

About this study

The experience of infertility can cause significant emotional instability, especially for patients awaiting In Vitro Fertilization (IVF) treatment, generating anxiety, stress, and depressive symptoms. This study is a randomized clinical trial assessing the effectiveness of aromatherapy in improving mental health and quality of life in women undergoing infertility treatment. 120 participants will be randomized into three groups (Intervention, Placebo, and Control). The intervention involves the inhalation of true lavender essential oil (Lavandula angustifolia) for four weeks.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * Female gender, age over 18 years. * Diagnosis of infertility with indication for In Vitro Fertilization (IVF). * Patients on the waiting list at HC-UFMG. * Agreement not to practice other mind-body or herbal complementary therapies during the study. * DASS-21 screening score compatible with at least mild anxiety, stress, and/or depression. * No aversion to inhaling essential oil or synthetic lavender essence. Exclusion Criteria: * Severe neurological, psychiatric, or clinical disorders (e.g., schizophrenia, severe depression) that prevent participation. * Use of medications that could confound the primary outcome (e.g., sleep medications, anxiolytics, antidepressants, neuroleptics) in the 30 days prior to or during the study. * Known allergy to lavender products. * Pregnancy during the study period. * Use of essential oils in the last 90 days.

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.